|
Volumn 856, Issue 1-2, 2007, Pages 198-204
|
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910.Na, a mitotic progression modulator, in human plasma
|
Author keywords
High performance liquid chromatography (HPLC); LC MS MS; Mass spectrometry (MS); ON 01910.Na; Pharmacokinetics
|
Indexed keywords
ACETONITRILE PROTEIN PRECIPITATION;
TANDEM MASS SPECTROMETRY;
ACETONITRILE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PHARMACOKINETICS;
PLASMA (HUMAN);
PROTEINS;
ACETONITRILE;
AMMONIUM ACETATE;
ANTINEOPLASTIC AGENT;
ON 01910.NA;
TEMAZEPAM;
UNCLASSIFIED DRUG;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CANCER PATIENT;
CONTROLLED STUDY;
DRUG STABILITY;
ELECTROSPRAY;
HUMAN;
LIQUID CHROMATOGRAPHY;
PLASMA;
PRECIPITATION;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
TANDEM MASS SPECTROMETRY;
CHROMATOGRAPHY, LIQUID;
GLYCINE;
HUMANS;
MITOSIS;
REFERENCE STANDARDS;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
SULFONES;
TANDEM MASS SPECTROMETRY;
|
EID: 34548140060
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2007.05.047 Document Type: Article |
Times cited : (9)
|
References (2)
|